- Yapan Bio Private Limited specializes in process development, characterization, and phase I and II GMP manufacturing services for vaccines and biologics.
- Piramal has held a stake in Yapan Bio since 2021, enabling the Company to provide a broad range of capabilities across biologics development and manufacturing.
- This acquisition transforms Yapan Bio from Piramal's associate company to its subsidiary, enhancing the Company's ability to offer complex, integrated large molecule CDMO services.
MUMBAI, India, Aug. 19, 2026 /PRNewswire/ -- Piramal Pharma Ltd. (NSE: PPLPHARMA) (BSE: 543635) ("PPL) has completed the acquisition of an incremental 40.67% stake in Yapan Bio Private Limited ("Yapan Bio"), a Hyderabad-based CDMO specializing in vaccines and biologics for an aggregate cash consideration of ₹76 crore, or $7.95M USD. As a result of this transaction, PPL now owns 74% of Yapan Bio's equity, making Yapan Bio a subsidiary of PPL.
Finalized on August 18, 2026, the acquisition marks a major step forward in PPL's long-range plan to expand its presence in the biologics sector. With the finalization of this deal, PPL will fully embed the subsidiary's advanced large molecule capabilities into its integrated service offering, enabling the Company to offer customers broader services in the space and expanding its ability to develop and scale complex biologic therapies with greater efficiency. The subsidiary will continue to operate within the structure of Piramal Pharma Solutions (PPS), the CDMO arm of PPL.
Yapan Bio also directly supports ADCelerate™ — PPS's fixed-price, integrated platform that streamlines Phase I ADC development from R&D to GMP in as little as 12 months. This acquisition further enhances ADCelerate™ and reinforces PPL's ability to deliver life-saving ADCs to market with speed and consistency.
"This strategic investment doesn't just fuel our long-term growth; it also puts Patient Centricity into action," said Peter DeYoung, CEO, Piramal Global Pharma. "By integrating Yapan Bio's specialized expertise into our global network, we're empowering our partners to meet a rising global demand for complex biologics and helping patients worldwide secure continued access to the therapies they need."
About Piramal Pharma Solutions
Piramal Pharma Solutions (PPS) is a Contract Development and Manufacturing Organization (CDMO) offering end-to-end development and manufacturing solutions across the drug life cycle. We serve our customers through a globally integrated network of facilities in North America, Europe, and Asia. This enables us to offer a comprehensive range of services including drug discovery solutions, process and pharmaceutical development services, clinical trial supplies, commercial supply of APIs, and finished dosage forms. We also offer specialized services such as the development and manufacture of highly potent APIs, antibody-drug conjugations, sterile fill/finish, peptide products and services, and potent solid oral drug products. PPS also offers development and manufacturing services for biologics including vaccines and gene therapies, made possible through Piramal Pharma Limited's subsidiary, Yapan Bio Private Limited.
For more information visit: Piramal Pharma Solutions | LinkedIn| Facebook | X
About Piramal Pharma Limited
Piramal Pharma Limited (PPL, NSE: PPLPHARMA I BSE: 543635), offers a portfolio of differentiated products and services through its 17 global development and manufacturing facilities and a global distribution network in over 100 countries. PPL includes Piramal Pharma Solutions (PPS), an integrated contract development and manufacturing organization; Piramal Critical Care (PCC), a complex hospital generics business; and the Piramal Consumer Healthcare business, selling over-the-counter consumer and wellness products. In addition, one of PPL's associate companies, Abbvie Therapeutics India Private Limited, a joint venture between Abbvie and PPL, has emerged as one of the market leaders in the ophthalmology therapy area in the Indian pharma market.
For more information, visit: Piramal Pharma | LinkedIn
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Piramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited
In the news release, Rayence Breaks the Boundaries of Point-of-Care Imaging with the Launch of Integrated Portable X-ray Diagnostic Solutions 'Anywhere-M' and 'Anywhere-V', issued 18-Aug-2026 by Rayence over PR Newswire, we are advised by the company that the first paragraph has been updated and a special note [(AI-generated image)] should be added into photo caption so it should read: [Rayence expands the boundaries of point-of-care imaging with its new integrated portable X-ray diagnostic solutions, Anywhere-M for human healthcare and Anywhere-V for veterinary and field animal care. (AI-generated image)] as originally issued inadvertently. The complete, corrected release follows:
Rayence Breaks the Boundaries of Point-of-Care Imaging with the Launch of Integrated Portable X-ray Diagnostic Solutions 'Anywhere-M' and 'Anywhere-V'
- Integrated all-in-one workflow combining a portable X-ray generator, detector, and imaging software
- Powered by Rayence's proprietary SHINE denoising algorithm and military grade detector durability for emergency, disaster relief, and field diagnostics
- Cost effective, high performance solution designed to accelerate the expansion of telemedicine and mobile healthcare worldwide
HWASEONG, South Korea, Aug. 19, 2026 /PRNewswire/ -- Rayence, a global leader in digital X-ray detectors and medical imaging solutions, today announced the launch of its next-generation portable X-ray diagnostic solutions, designed to extend diagnostic imaging beyond the traditional hospital environment and bring high quality care directly to the point of need. The new lineup includes 'Anywhere-M', a mobile imaging solution for human healthcare, and 'Anywhere-V', a portable diagnostic solution optimized for veterinary and field animal care.
Unlike conventional portable systems that simply bundle individual devices together, the 'Anywhere' series is a fully integrated all-in-one diagnostic solution that seamlessly combines a portable X-ray generator, a high resolution digital detector, and Rayence's dedicated imaging software platforms, 'Xmaru Pro' for human healthcare and 'VetView Pro' for veterinary applications, into a unified imaging workflow.
Designed for effortless interoperability, the system minimizes setup complexity and eliminates time consuming calibration procedures, enabling healthcare professionals to acquire diagnostic quality images almost instantly. The solution is expected to significantly enhance diagnostic efficiency in emergency departments, trauma centers, disaster relief operations, military medical units, and home healthcare settings, where rapid decision making is critical and access to conventional imaging infrastructure is limited.
Anywhere-M: Portable Imaging Solution for Emergency and Home Healthcare
The Anywhere-M solution overcomes one of the most significant limitations of portable X-ray systems, reduced output efficiency, through Rayence's proprietary 'SHINE (Smart High-resolution Image Noise Elimination)' technology.
SHINE is an advanced image processing algorithm that dramatically improves the signal-to-noise ratio (SNR) of low dose X-ray images, producing exceptionally clear, high resolution diagnostic images without requiring additional hardware. This enables clinicians to obtain hospital grade image quality in challenging environments while minimizing patient radiation exposure.
The system supports real time, high resolution imaging across a wide range of anatomical regions, including the chest, shoulder, knee, skull, and hand, empowering medical professionals to make confident diagnostic decisions wherever care is delivered.
To maximize reliability in demanding environments, the hardware has been engineered with durability as a top priority. The wireless digital detector has successfully passed a 1.2 meter drop test in accordance with U.S. military standards (MIL-STD-810H). This ensures dependable performance in emergency response and field operations where accidental drops are common.
Additional features include an anti-slip protective bumper, hot swappable batteries that allow uninterrupted operation without powering down the detector, and a patient load capacity of up to 140 kg. These features enable safe imaging from the extremities to the abdomen.
The portable generator is equipped with a high capacity battery capable of delivering up to 493 exposures on a single charge. For improved usability in low-visibility environments, it also features an LED collimator and dual laser positioning system, allowing operators to accurately visualize the exposure field before imaging.
Anywhere-V: Portable Veterinary Imaging for Field and Large-Animal Practice
The newly introduced Anywhere-V package delivers a practical, high performance imaging solution tailored to the unique demands of veterinary medicine, including equine hospitals, livestock farms, wildlife rescue centers, and large animal field practice.
By offering an affordable alternative to expensive fixed imaging systems, Anywhere-V lowers the barrier to adopting advanced diagnostic technology and enables veterinary professionals to establish high quality imaging capabilities at a significantly lower cost.
The package supports multiple portable generator options including X-Lite, PXP-40HF, and VET-20BT, available in both battery powered and AC powered configurations to accommodate diverse clinical environments.
Its wireless detector offers an optional battery capable of operating for up to 16 hours, maximizing mobility during extended field operations.
Like the human healthcare solution, Anywhere-V incorporates Rayence's proprietary SHINE technology, enabling veterinarians to clearly identify subtle fractures and soft tissue abnormalities even under challenging field conditions.
A Rayence spokesperson commented,
"Anywhere-M and Anywhere-V represent a new generation of truly integrated mobile imaging systems engineered to optimize the performance of the X-ray generator, detector, and imaging software as a single, unified platform. By eliminating the limitations imposed by location and infrastructure, these solutions establish a new benchmark for point-of-care diagnostic imaging. We are confident they will set a new standard for field diagnostics and strengthen Rayence's leadership in the U.S. medical and veterinary imaging markets."
About Rayence
Rayence (KOSDAQ: 228850) is a global leader in the development and manufacturing of high performance digital X-ray detectors and advanced medical imaging solutions. Built upon proprietary core technologies and a strong commitment to research and development, Rayence continues to deliver innovative imaging technologies that empower healthcare professionals worldwide and strengthen its position as a trusted partner in the global medical imaging industry.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Rayence Breaks the Boundaries of Point-of-Care Imaging with the Launch of Integrated Portable X-ray Diagnostic Solutions 'Anywhere-M' and 'Anywhere-V'
